Advert - HRA Pharma UK

• Date posted
  01 February 2014
• Sanction
  Advertisement,
• Case number/s
  AUTH/2624/8/13 - Public Health Specialist v HRA Pharma

As a result of emails sent by a representative to a health professional regarding the provision of an emergency contraception service and the use of ellaOne (ulipristal acetate), HRA Pharma was ruled in breach of the following clauses of the Code:

Clause 2 - Bringing discredit upon, and reducing confidence in, the pharmaceutical industry.

Clause 7.2 - Making a misleading claim

Clause 7.10 - Making an exaggerated claim

Clause 8.2 - Disparaging a service provision

Clause 9.1 - Failing to maintain high standards

Clause 15.2 - Failing to maintain a high standard of ethical conduct